[1]  Bernabeu C, Conley BA, Vary CPH. Novel biochemical pathways of endoglin in vascular cell physiology [J]. Journal of  Cellular Biochemistry. 2007, 102(6): 1375-88.

[2] Zhu Y, Sun Y, Xie L, et al. Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells [J]. Stroke. 2003, 34(10): 2483-8.

[3] Fonsatti E, Sigalotti L, Arslan P, et al. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies [J]. Curr Cancer Drug Targets. 2003, 3(6): 427-32.

[4] Lastres P, Bellon T, Cabañas C, et al. Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen [J]. Eur J Immunol. 1992, 22(2): 393-7. 

[5] Castonguay R, Werner ED, Matthews RG, et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth [J]. J Biol Chem. 2011, 286(34): 30034-46. 

[6] Nolan-Stevaux O, Zhong W, Culp S, et al. Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies [J]. PLoS One. 2012, 7(12): e50920.